Abiopharma

Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026

Xeris Announces Details for XP-8121 Program Overview Webinar

Eikon Therapeutics to Participate in Investor Conferences in September 2026

Reklaim Ltd Reports Q2 2026 Results: Revenue Up 103%, Net Income of $723,000

Abercrombie & Fitch Co. Reports Second Quarter Fiscal 2026 Results

Better, Coinbase Announce General Availability of First Token-backed, Conforming Mortgage to Expand Homeownership Access for a New Generation of Mortgage Borrowers

Brandywine Realty Trust Announces Expiration of Tender Offer for the 2029 Notes

APi Group Announces Participation in 2026 Jefferies Global Industrials Conference

BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM

New Form N-PX - BLACKROCK MUNIYIELD QUALITY FUND III, INC. <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001438934-26-001730 <b>Size:</b> 3 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0000950103-26-012892 <b>Size:</b> 326 KB

New Form N-PX - BLACKROCK MUNIYIELD NEW YORK QUALITY FUND, INC. <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001438934-26-001729 <b>Size:</b> 3 KB

New Form 424B2 - UBS AG <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001839882-26-041503 <b>Size:</b> 644 KB

New Form N-PX - BLACKROCK INCOME TRUST, INC. <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001438934-26-001727 <b>Size:</b> 3 KB

Employee Stock Option/ Share Scheme: Grant of Share Awards